The U.S. Food and Drug Administration (FDA) granted regular approval to the combination of rituximab and hyaluronidase human for adult patients with chronic lymphocytic leukemia. More >
Learn From Experts
The FocusOnCLL.org website is designed to provide helpful information and resources to patients, caregivers, physicians, and others affected by chronic lymphocytic leukemia (CLL).
Learn about CLL, treatment options, research and more from exclusive interviews with some of the world's leading lymphoma experts.
Getting the Facts
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are B-cell malignancies. CLL and SLL are essentially the same disease, with slightly different manifestations. CLL tends to be an indolent (slow-growing) cancer. However, over time, it can progress to a more aggressive type of lymphoma. Approximately 15,000 new cases of CLL are diagnosed annually.
Hear From the Community
Everyone's lymphoma story is unique and special.
Read about CLL patients, survivors and caregivers' journey with the disease, lessons learned and words of advice.